Sector portfolio · Private equity · United States
OrbiMed's Pharma portfolio
OrbiMed has backed 26 Pharma startups in rounds we track, $3.7B between them, shown by the stage each has reached. The best-funded is Mineralys Therapeutics.
26startups backed
4stages
$3.7Braised between them
Stage not reportedbiggest stage
Funding by segment
- Stage not reported$1.8B12
- Series B$949M7
- Series C and later$804M5
- Series A$150M2
Where they are based
- United States23$3.5B
- Canada2$150M
- United Kingdom1$54M
United States
Canada
United KingdomFounded
8Earlier
12
13
314
115
116
117
118
219
220
121
22
23
124
125
26
4 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M0
- $10M to $50M5
- $50M to $250M17
- $250M to $1B4
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
22 of 26 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States23
- Canada2
- United Kingdom1
Startups by country, 3 countries in all.
Segment by segment
Stage not reported
12 startups · $1.8B raised
Mineralys TherapeuticsMineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.United States$788M
Cullinan TherapeuticsCullinan Therapeutics is a developer of an externally sourced cancer therapeutics used to end a drug program quickly.United States$280M
Harmony BiosciencesHarmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.United States$248M
Verastem OncologyVerastem is a biopharmaceutical company developing new medicines to improve the lives of patients with RAS/MAPK pathway-driven cancers.United States$90M
Whitehawk TherapeuticsWhitehawk Therapeutics, a clinical-stage oncology therapeutics firm, applies cutting-edge technologies to well-established tumor biology.United States$88M
Shattuck LabsShattuck Labs is a biotechnology company that provides novel class biologic medicines for the treatment of cancer and autoimmune disease.United States$75M- NNeurAxonNeurAxon discovers and develops pain therapeutics targeted on neuronal nitric oxide synthase.Canada$57M
EUSA PharmaEUSA Pharma is a pharmaceutical company developing and licensing late-stage oncology, pain control, and critical care products.United Kingdom$54M
Series B
7 startups · $949M raised
Corvus PharmaceuticalsCorvus Pharmaceuticals is a clinical-stage biopharmaceutical company.United States$310M
Adicet BioAdicet Bio is a biotechnology company discovering and developing first-in-class allogeneic gamma delta CAR t cell therapies for caUnited States$175M
CurevoCurevo is a clinical-stage biotech firm that focuses on producing vaccines.United States$110M
Pathalys PharmaPathalys Pharma is a private biopharmaceutical company based in Raleigh, North Carolina, founded in 2021.United States$105MClementia PharmaceuticalsClementia is a clinical-stage company innovating treatments for people with ultra-rare bone disorders.Canada$93M
Pinnacle MedicinesPinnacle Medicines is a peptide drug discovery company that provides peptide modality for medical needs.United States$90M
Rempex PharmaceuticalsRempex Pharmaceuticals engages in the discovery and development of antibacterial drugs for antibiotic resistance.United States$68M
Series C and later
5 startups · $804M raised
ACELYRINACELYRIN is a biopharma company that identifies, acquires, and accelerates the development and commercialization of life-changing therapies.United States$300M
ORIC PharmaceuticalsORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance.United States$248M
Aduro BioTechAduro BioTech is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapies.United States$143M
Targanta TherapeuticsTarganta Therapeutics is a biopharma CompanyUnited States$70M
Auxilium PharmaceuticalsAuxilium Pharmaceuticals (NASDAQ: AUXL) was founded in 1999 to develop and market pharmaceutical products that focus on urology anUnited States$43M
Series A
2 startups · $150M raised
Rampart BioscienceRampart Bioscience is a private biotechnology company focused on developing non-viral, DNA-based gene medicines for genetically drUnited States$85M
Helicore BiopharmaHelicore Biopharma is a private biopharmaceutical company based in San Mateo, California, focused on developing innovative weight-United States$65M
How this map is made. Every startup here works in Pharma and has raised money in a round we track that names OrbiMed as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosSector portfolioOrbiMed's Biotech portfolio176 startups · $28BSector portfolioOrbiMed's Healthtech portfolio12 startups · $1.4BPortfolio mapOrbiMed portfolio map221 startups · $34BCo-investorsWho invests with OrbiMed159 co-investorsSector portfolioRA Capital Management's Biotech portfolio197 startups · $38BSector portfolioPioneer Fund's AI portfolio171 startups · $2.8B
Raising from investors like OrbiMed?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.